Literature DB >> 3143050

Effects of the antiserum against a fraction enriched in scrapie-associated fibrils on the scrapie incubation period in mice.

M Ito1, M Shinagawa, S Doi, S Sasaki, H Isomura, K Takahashi, H Goto, G Sato.   

Abstract

An antiserum against a fraction enriched for scrapie-associated fibrils (SAF), was examined for its effects on scrapie incubation period by inoculating mice either intraperitoneally or intracerebrally with various dilutions of the serum mixed with scrapie-infected mouse brain homogenate. After intraperitoneal inoculation the mean time of the incubation period increased with increasing concentrations of the antiserum in a statistically significant fashion, when the serum dilutions were made with phosphate-buffered saline. After intracerebral inoculation, however, there were no statistically significant differences between the control group and any of the antiserum-groups. When the antiserum dilutions were made with pre-immune serum, the mice inoculated intraperitoneally also showed no significant differences between the two groups. These results indicate that the specific antibodies to SAF have no effect on the scrapie infectivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143050     DOI: 10.1111/j.1348-0421.1988.tb01436.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

Review 1.  Prion liposomes.

Authors:  R Gabizon; S B Prusiner
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

2.  Comparative sequence analysis and expression of bovine PrP gene in mouse L-929 cells.

Authors:  J Yoshimoto; T Iinuma; N Ishiguro; M Horiuchi; M Imamura; M Shinagawa
Journal:  Virus Genes       Date:  1992-11       Impact factor: 2.332

3.  Detection of PrPSc in sheep at the preclinical stage of scrapie and its significance for diagnosis of insidious infection.

Authors:  Y Muramatsu; A Onodera; M Horiuchi; N Ishiguro; M Shinagawa
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.